Revvity (NYSE:RVTY – Get Rating) and Precipio (NASDAQ:PRPO – Get Rating) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability. Profitability This table compares Revvity and Precipio’s net margins, return on equity […]
Revvity (NYSE:RVTY – Get Rating) and Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Earnings and Valuation This table compares Revvity and Rapid Micro […]
Precipio (NASDAQ:PRPO – Get Rating) and Revvity (NYSE:RVTY – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations. Analyst Recommendations This is a summary of current ratings and recommmendations for […]
Revvity (NYSE:RVTY – Get Rating) is one of 44 public companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Revvity to related companies based on the strength of its valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership. Dividends Revvity pays an annual dividend of $0.28 […]
StockNews.com started coverage on shares of Revvity (NYSE:PKI – Get Rating) in a report issued on Saturday. The firm issued a hold rating on the medical research company’s stock. Other equities research analysts have also recently issued reports about the stock. Credit Suisse Group restated a neutral rating and set a $160.00 price target on […]